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ABSTRACT :  The results of this study has revealed a significant increase in I
131 uptake of 
cultivated thyroid gland in the media containing petroleum ether extract of Commiphora mukul.  
Besides, T3 resin uptake, protein bound iodine as well as free thyroxine index in the media are 
also observed to be significantly (P 0.001) increased.  When explants are cultivated in the media 
containing melatonin, there is significant depression in thyroid I
 131 uptake and media T3 resin 
uptake, protein bound iodine as well as free thyroxine index.  Further, the inhibitory action of 
melatonin has been antagonized when similar explants are cultivated in the media containing 
melatonin and P.E. extract  of c. mukul together thus, C. mukul may be useful in the management 
of hypothyroidism and its associated disorders like, hypercholesterolemia, hyperlipidemia, 
atherosclerosis etc. 
Introduction 
Lipoprotein metabolism is known to be 
affected by alterations in the level of thyroid 
functions in human as well as in rats where 
hypercholesterolemia has been consistently 
demonstrated in hypothyroidism (Story et. 
Al. 1974, Byers et. al. 1973, Mathe et. al. 
1976 and Kutly et. al.1978). Commiphora 
mukul has been proved to be a potent 
hypolipidemic, hypocholesterolaemic and 
antiatherosclerotic agent in clinical as well 
as experimental studies (Tripathi et. al. 
1968, Satyavati et. al. 1969, Nityanand et. 
al. 1974 & 1975). Different fractions of this 
drug were used in the prevention of 
experimentally induced 
hypercholesterolemia in  chick and 
maximum activity was recorded in the 
petroleum ether extract and effective 
component of this fraction was identified as 
a ketosteroid with the molecular formula C21 
H30  O3  (Tripathi 1973). However, the 
hypocholesterolaemic and hypolipidemic 
action of this drug has been reported through 
thyroid gland from our in vivo studies.  
Nevertheless, the mode of action of this drug 
on thyroid ahs not yet been clearly 
understood.  It has been proposed that its 
stimulatory effect on thyroid might have 
been exerted via pituitary or hypothalamus 
or it may have a direct action, Thus, it was 
intended to investigate the action of C. 
mukul on thyroid gland in tissue culture.  
Besides, the thyroid stimulating capacity of 
this drug has also been found out using an 
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Material and Methods  
Young male mice (about 6-7 weeks old) 
were employed in this study and their 
thyroid glands were carefully dissected out 
under aseptic condition, washed thoroughly 
with Tyrode Solution after removing its 
extra-adherent tissue and then grown in vitro 
(Fell & Weiss 1965) in modified dulbecco’s 
eagles medium (BIOS) supplement with 
10% human serum (heat inactivated at 56
oC) 
at 37.5
oC in a water jacket incubator and 
under the gas phase of 50% oxygen, 45% 
nitrogen and 5% Co2 Further, thyroid gland 
was also cultivated in the media containing 
different doses of melatonin (0.25 ng/ml and 
0.50 ng/ml) and P.E. extract of C. mukul 
(100 ng/ml and 200 ng/ml). The most 
effective dose of these chemicals were 
selected and a separate media was prepared 
where the effective dose of melatonin (0.50 
ng/ml) and P.E. extract of C. mukul (200 
ng/ml) were added together. 
Thyroid gland was cultivated for eight days 
and the I 
131 uptake of cultured explants was 
studied after introducing 1.0μci I
131 into the 
medium 4 hours prior to harvesting them.  
The percentage    I
131 uptake was calculated 
per minute.  The used culture media was 
collected on each alternate days and 
subjected for the estimation of T3  resin 
uptake (Clark 1963) and protein bound 
iodine   (Acland 1957) which were based on 
our observations that released 
iodothyronines bind with media proteins 
under in vitro conditions.  Further, media 
free thyroxine index was calculated (Clark 
1965) which corresponds to the actual free 
thyroxine level. 
Results 
I
131  uptake of the cultivated explants was 
observed to be maximum i.e 3.65±0.28 on 
the fourth day in the normal culture.  
However, there was a decline in I
131 uptake 
when the explants were grown in the media 
containing melatonin.  In the case of low 
dose of melatonin (0.25 ng/ml)       I
131 
uptake was minimum i.e. 2.25±0.19 on the 
8
th  day after culture and was significant 
(P<0.02) whereas in the high dose, I
131 
uptake was maximally depressed i.e. 1.65 ± 
0.28 on the 2
nd  day and was significant 
(P<0.01) as compared to control Further 
there was a significant increase in I
131 
uptake when the explants were cultivated in 
the media containing P.E extract of C. 
mukul. The increase in I
131 uptake was dose 
related i.e. it was much more pronounced 
and significant (P< 0.001) in the case of 
high dose (200 μg/ml)  of P.E extract of C. 
mukul.  A significant increase in I 131 
uptake of culture explants was also  
observed when thyroid gland of similar 
animals were grown in the media containing 
both melatonin as well as P.E. extract of C. 
mukul (Table 1). 
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TABLE I 
I
131 Uptake of Thyroid Gland After Different Treatment in Vitro (% Uptake; Mean ± SD) 
Groups  Days after Culture 
II  III  IV  VIII 
Control  2.5 ±0.17  3.95 ±0.28  3.35 ±0.36  2.85 ±0.12 
Melatonin 
0.25ng/ml 
2.41  ±0.27  3.5 ±0.37  2.75* ±0.30  2.25** ±0.19 
0.50 ng/ml  1.65***± 0.28  2.88* ±0.58  3.18 ±0.29  2.65 ±0.31 
P.E extract of C. 
mukul  100 μg/ml 
3.19 ±0.21  4.45±0.26  4.74±0.05  3.98±0.41 
200 μg/ml  5.15****±0.03  6.15****±6.61  6.15****±0.32  5.45****±0.17 
P.E extract of C. 
mukul 200 μg/ml + 
Melatonin 0.05 
ng/ml 
3.31**±0.11  5.25***±0.22  5.75 ****±0.31  4.55****±0.23 
 
*P  <   0.05 as compared to control value 
** P  <   0.02 as compared to control value 
*** P  <   0.01 as compared to control value 
**** P <   0.001 as compared to control value 
 
Maximum T3 resin uptake in the used 
culture media of normal culture was 
observed on the 4
th day after culture and it 
was 43.1 ± 1.7, but in the melatonin treated 
group of explants there was a gradual 
decline in T3 resin uptake upto 6
th day after 
culture and it followed a little increase on 
the 8
th day.  However, the depression in T3 
resin uptake was more significant in the case 
of high dose of melatonin (0.50 ng/ml).  
when thyroid gland was cultivated in the 
media containing P.E. extract of C. mukul, 
there  was a gradual increase in media T3 
resin uptake which was more elevated and 
highly significant (P. 0.001) in the high 
dose.  An increasing T3  resin uptake was 
further observed when the explants were 
cultivated in the media containing melatonin 
as well as P.E. extract of C. mukul (Table 
2). 
The media protein bound  iodine (PBI) of 
the unused culture media was 1.8 ± 0.04, 
However, in the control group the media 
PBI was almost double of the value obtained 
for unused culture media.  In the melatonin 
treated group, the media PBI was observed 
to decline.  Maximum depression was found 
on the 4
th day in the high dose of melatonin 
and it did not change much in the later 
period.  In the case of P.E. extract of C. 
mukul treated group of explants the media 
PBI increased gradually and more 
pronounced and significant increase was 
observed in the high dose  (Table 3). 
The calculated free thyroxine index of the 
media in the melatonin treated group was 
observed to undergo a decline which was 
highly significant (P< 0.001) in the high 
dose as compared to control.  However, 
media free thyroxine index was observed to Page 23-28 
 
increase in the C. Mukul treated group and 
the increase was pronounced and significant 
in the high dose (200 μg/ml).  further, 
increased free thyroxine index was also 
observed in the group where explants were 
cultivated in the media containing melatonin 
as well as P. E. extract of C. mukul together 
(Table 4). 
Discussion  
This study has delineated that melatonin 
treatment to culture explants brought about a 
decline in I
131  uptake of the cultivated 
thyroid gland where it is significant only in 
the early period of culture in the case of high 
dose while in the later period in the case of 
low dose or melatonin. However, such 
variation could be due to dose response of 
melatonin.  Besides, there is highly 
significant  depression in T3  resin  uptake, 
PBI and free thyroxine index in the media.  
It indicates that melatonin affects hormone 
releasing activity of thyroid gland more 
significantly than that of iodide 
accumulating capacity.  However, our 
results confirm that the inhibitory action of 
melatonin on thyroid function is directly 
exerted at the cell level.  Regarding the 
mechanism through which melatonin 
influences thyroid activity is not yet clear.  
However, our earlier findings shows that 
melatonin suppresses thyroid function 
through specific melatonin binding proteins 
in thyroid gland (Singh et. al. 1981). 
On the other hand the explants cultivated in 
the media containing P.E. extract of C. 
mukul has revealed a significant increase in 
I
131 uptake of cultivated thyroid explants as 
well as T3  resin uptake, PBI and free 
thyroxine index in the media.  These results 
of this study suggest that C. mukul 
stimulates thyroid function which is directly 
exerted at the cell level.  Further, the 
inhibitory effect of melatonin has been 
completely antagonized when the similar 
explants have been grown in the media 
containing melatonin as well as P.E. extract 
of C. mukul.  Thus, it again confirms that C. 
mukul is capable to stimulate the thyroid 
cell directly and the stimulating capacity of 
this drug is so much intense that it fully 
counteracts the inhibitary action of 
melatonin.  Since biosynthesis of thyroid 
hormones is mediated through many 
enzymes, so it is most likely that the 
stimulatory effect of C. mukul might involve 
one or the other enzyme (S) responsible for 
the thyroid hormone biogenesis.  Thus, this 
drug may prove to have a good scope in the 
management of hypothyroidism and its 
associated disorders. 
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TABLE II 
T3- Resin Uptake of Media After Different Treatment to Thyroid Gland in Vitro  
(% Uptake; Mean ± SD) 
Groups  Days after Culture 
II  III  IV  VIII 
Control  38.0 ±3.4  43.1 ±1.7  41.5 ±0.5  38.7 ±1.7 
Melatonin 
0.25ng/ml 
37.1  ±3.9  35.1* ±4.3  33.5** ±2.3  36.3 ±2.7 
0.50 ng/ml  31.2*± 1.7  30.5*** ±3.6  29.7**** ±2.7  34.5** ±1.1 
P.E extract of C. 
mukul  100 μg/ml 
39.0 ±1.8  44.1±2.0  47.5****±0.05  3.98±0.41 
200 μg/ml  47.3±2.9  54.0±3.0  56.6****±2.1  52.2****±1.4 
P.E extract of C. 
mukul 200 μg/ml + 
Melatonin 0.05 
ng/ml 
36.59±2.15  45.13±3.12  48.59**±2.56  46.43***±3.17 
 
*P  <   0.05   as compared to control value 
** P  <   0.02   as compared to control value 
*** P  <   0.01   as compared to control value 
**** P <   0.001   as compared to control value 
 
TABLE III 
Media PBI  After Different Treatment to Thyroid Gland in Vitro  
(μg % Uptake; Mean ± SD) 
Groups  Days after Culture 
II  IV  VI  VIII 
Control  4.10 ±0.71  4.42 ±0.97  4.81 ±0.26  4.62 ±0.22 
Melatonin 
0.25ng/ml 
40.5  ±0.21  3.80 ±0.93  3.41 ±0.86  2.92 ±10.31 
0.50 ng/ml  3.15± 0.26  2.71 ±0.25  2.93*** ±0.83  2.72*** ±0.57 
P.E extract of C. 
mukul  100 μg/ml 
5.15 ±0.57  5.18±0.20  6.21***±0.19  6.28***±0.20 
200 μg/ml  6.23*±0.19  6.36**±0.26  7.63****±0.21  7.09±0.30 
P.E extract of C. 
mukul 200 μg/ml + 
Melatonin 0.05 
ng/ml 
3.28±0.19  5.31±0.21  5.78±0.32  4.49±0.31 
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*P  <   0.05    as compared to control  
** P  <   0.02   as compared to control  
*** P  <   0.01    as compared to control  
**** P <   0.001   as compared to control  
 
TABLE IV 
Free Thyroxine Index of Media After Different Treatment to Thyroid Gland in Vitro  
(Mean ± SD) 
Groups  Days after Culture 
II  IV  VI  VIII 
Control  5.22 ±0.28  6.53 ±0.68  6.80 ±0.47  6.07 ±0.88 
Melatonin 
0.25ng/ml 
4.97  ±0.27  4.50** ±0.47  3.91**** ±0.32  3.53*** ±0.19 
0.50 ng/ml  3.25***± 0.33  2.83**** ±0.23  2.60**** ±0.61  3.09**** ±0.18 
P.E extract of C. 
mukul  100 μg/ml 
6.01±0.35  7.96±0.61  5.96**±0.27  9.19***±0.36 
200 μg/ml  9.28**±0.25  11.53***±1.2  14.07****±0.67  12.76****±0.63 
P.E extract of C. 
mukul 200 μg/ml + 
Melatonin 0.05 
ng/ml 
6.54±0.79  9.33**±0.89  11.35****±1.09  10.98****±0.77 
 
*P  <   0.05   as compared to control value 
** P  <   0.02   as compared to control value 
*** P  <   0.01   as compared to control value 
**** P <   0.001   as compared to control value 
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